1) Wolf GT, Forastiere A, Ang K, et al: Workshop report: organ preservation strategies in advanced head and neck cancer-current status and future directions. Head and Neck 21: 689-693, 1999.
5) Baur M, Kienzer HR, Schweiger J, et al: Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial. Cancer 94(11): 2953-2958, 2002.